Effects of linezolid on staphylococcal adherence versus time of treatment

International Journal of Antimicrobial Agents

Volumn 23, Issue 3, 2004, Pages 226-234

  Pagano, Paul J ^a   Buchanan, Lewis V ^a   Dailey, Charlene F ^a   Haas, Joseph V ^a   Van Enk, Richard A ^b   Gibson, John K ^a  

^a PFIZER INC   (United States)

^b BRONSON METHODIST HOSPITAL   (United States)

Author keywords

Bacterial adherence; Indwelling medical devices; Linezolid; Staphylococcus epidermidis

Indexed keywords

LINEZOLID; POLYSTYRENE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENCY; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; SUSPENSION;

EID: 1442312070     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.07.012     Document Type: Conference Paper

References (31)

1. Mittelman MW. Recovery and characterization of biofilm bacteria associated with medical devices. In: Doyle RJ, editor, Methods in enzymology. Biofilms, vol. 310. New York: Academic Press; 1999.
2. Darouiche R.O. Device-associated infections: a macroproblem that starts with microadherence. Clin. Infect. Dis. 33:2001;1567-1572.
3. Schierholz J.M., Beuth J. Implant infections: a haven for opportunistic bacteria. J. Hosp. Infect. 49:2001;87-93.
4. Worthington T., Lambert P.A., Elliott T.S. Is hospital-acquired intravascular catheter-related sepsis associated with outbreak strains of coagulase-negative staphylococci? J. Hosp. Infect. 46:2000;130-134.
5. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science. 284:1999;1318-1322.
6. Rupp M.E., Archer G.L. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect. Dis. 19:1994;231-243.
7. Donlan R.M. Biofilm formation: a clinically relevant microbiological process. Clin. Infect. Dis. 33:2001;1387-1392.
8. Costerton J.W. Introduction to biofilm. Int. J. Antimicrob. Agents. 11:1999;217-221.
9. Rupp M.E., Hamer K.E. Effect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidis. J. Antimicrob. Chemother. 41:1998;155-161.
10. Gristina A.G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 237:1987;1588-1595.
11. Ferrara A., Dos Santos C., Lupi A. Effect of different antibacterial agents and surfactant protein-A (SP-A) on adherence of some respiratory pathogens to bronchial epithelial cells. Int. J. Antimicrob. Agents. 17:2001;401-405.
12. Gemmel CG, Lorian V. Effects of low concentrations of antibiotics on bacterial ultrastructure, virulence, and susceptibility to immunodefenses: clinical significance. In: Lorian V, editor. Antibiotics in laboratory medicine, 4th ed. Baltimore: Williams & Wilkins; 1996.
13. Perez-Giraldo C, Rodriguez-Benito A, Moran FJ, Hurtado C, Blanco MT, Gomez-Garcia AC. In-vitro slime production by Staphylococcus epidermidis in presence of subinhibitory concentrations of ciprofloxacin, ofloxacin and sparfloxacin. J Antimicrob Chemother 1994;33:845-8.
14. Khardori N., Wong E., Nguyen H.et al. Effect of subinhibitory concentrations of clindamycin and trospectomycin on the adherence of Staphylococcus epidermidis in an in vitro model of vascular catheter colonisation. J. Infect. Dis. 164:1991;108-113.
15. Moellering R.C. Linezolid: the first oxazolidinone antimicrobial. Ann. Intern. Med. 138:2003;135-142.
16. Clemett D., Markham A. Linezolid: new drug profile. Drugs. 59:2000;815-827.
17. Giampaolo C., Cinelli R., Paradisi F. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic. Int. J. Antimicrob. Agents. 16:2000;527-530.
18. Tojo M., Yamashita N., Goldmann D.A., Pier G.B. Isolation and characterization of a capsular polysaccharide adhesin from Staphylococcus epidermidis. J. Infect. Dis. 157:1988;713-722.
19. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically approved standard, fifth ed. NCCLS document M7-A5 (ISBN 1-56238-394-9). Wayne, PA, USA: NCCLS; 2000.
20. Christensen GD, Simpson WA, Anglen JO, Gainor BJ. Methods for evaluating attached bacteria and biofilms. In: An YH, Friedman RJ, editors, Handbook of bacterial adhesion: principles, methods, and applications. Totowa: Humana Press; 2000.
21. Deighton M.A., Balkau B. Adherence measured by microtiter assay as a virulence marker for Staphylococcus epidermidis infections. J. Clin. Microbiol. 28:1990;2442-2447.
22. Montgomery DC. Design and analysis of experiments. New York: Wiley; 1991.
23. Gibson JK, Buchanan LV, Dailey CF, LeMay RJ, Pagano PJ. Anti-adhesion effects of linezolid on staphylococcal isolates from patients with catheter-related bloodstream infections. In: Program and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, September 27-30, 2002, San Diego, CA. Washington, DC: American Society for Microbiology; 2002 [abstract no. C1-1606].
24. Projan SJ, Novick RP. The molecular basis of pathogenicity. In: Crossley KB, Archer GL, editors, The Staphylococci in human disease. New York: Churchill Livingstone; 1997.
25. Rachid S., Ohlsen K., Witte W., Hacker J., Ziebuhr W. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44:2000;3357-3363.
26. McKenney D., Hubner J., Muller E., Wang Y., Goldmann D.A., Pier G.B. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect. Immun. 66:1998;4711-4720.
27. Mack D., Fischer W., Krokotsch A. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol. 178:1996;175-183.
28. Braga P.C., Sasso M.D., Sala M.T. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence. J. Antimicrob. Chemother. 45:2000;15-25.
29. Mollitt D.L. Infection control: avoiding the inevitable. Surg. Clin. North Am. 82:2002;365-378.
30. Schmidt A.H., Swiontkowski M.F. Pathophysiology of infections after internal fixation of fractures. J. Am. Acad. Orthop. Surg. 8:2000;285-291.
31. Moellering R.C. Pharmacokinetics of vancomycin. J. Antimicrob. Chemother. 14:1984;43-52.